BRPI0620845A2 - derivados de triterpenoquinona e triterpenofenol e sua aplicação para o tratamento de tumores e doenças parasitárias - Google Patents

derivados de triterpenoquinona e triterpenofenol e sua aplicação para o tratamento de tumores e doenças parasitárias Download PDF

Info

Publication number
BRPI0620845A2
BRPI0620845A2 BRPI0620845-2A BRPI0620845A BRPI0620845A2 BR PI0620845 A2 BRPI0620845 A2 BR PI0620845A2 BR PI0620845 A BRPI0620845 A BR PI0620845A BR PI0620845 A2 BRPI0620845 A2 BR PI0620845A2
Authority
BR
Brazil
Prior art keywords
alkyl
group
unsubstituted
substituted
independently hydrogen
Prior art date
Application number
BRPI0620845-2A
Other languages
English (en)
Portuguese (pt)
Inventor
Juan Carlos Lacal Sanjuan
Molina Ana Ramirez De
Monica Banez Coronel
Angel Gutierrez Ravelo
Ana Estevez Braun
Dulce Yazmin Mesa Siverio
Elisa Perez Sacau
Original Assignee
Univ La Laguna
Consejo Superior Investigacion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ La Laguna, Consejo Superior Investigacion filed Critical Univ La Laguna
Publication of BRPI0620845A2 publication Critical patent/BRPI0620845A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/723—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic
    • C07C49/727—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups polycyclic a keto group being part of a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/703—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups
    • C07C49/747—Unsaturated compounds containing a keto groups being part of a ring containing hydroxy groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/753—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of polycyclic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
BRPI0620845-2A 2005-12-30 2006-12-29 derivados de triterpenoquinona e triterpenofenol e sua aplicação para o tratamento de tumores e doenças parasitárias BRPI0620845A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200503263A ES2277568B1 (es) 2005-12-30 2005-12-30 Derivados de triterpenoquinona y triterpenofenoles y su aplicacion para el tratamiento de tumores y enfermedades parasitarias.
ESP200503263 2005-12-30
PCT/EP2006/070276 WO2007077203A2 (en) 2005-12-30 2006-12-29 Triterpenequinone and triterpenephenol derivatives and their application for the treatment of tumors and parasitic diseases

Publications (1)

Publication Number Publication Date
BRPI0620845A2 true BRPI0620845A2 (pt) 2011-11-22

Family

ID=37946257

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0620845-2A BRPI0620845A2 (pt) 2005-12-30 2006-12-29 derivados de triterpenoquinona e triterpenofenol e sua aplicação para o tratamento de tumores e doenças parasitárias

Country Status (11)

Country Link
EP (1) EP1976533A2 (es)
JP (1) JP2009522239A (es)
KR (1) KR20080083044A (es)
CN (1) CN101351211A (es)
AU (1) AU2006334359A1 (es)
BR (1) BRPI0620845A2 (es)
CA (1) CA2635318A1 (es)
ES (1) ES2277568B1 (es)
MX (1) MX2008008556A (es)
RU (1) RU2008131311A (es)
WO (1) WO2007077203A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007012668A (es) 2005-04-13 2008-03-11 Consejo Superior Investigacion Metodo in vitro para identificar compuestos para terapia del cancer.
WO2009026163A1 (en) * 2007-08-17 2009-02-26 Burnham Institute For Medical Research Compositions and methods for inhibiting growth and metastasis of melanoma
CN101434635B (zh) * 2007-11-16 2012-05-16 上海华拓医药科技发展股份有限公司 一类具抗肿瘤活性的水溶性酚性三萜化合物及其制备方法
US20100068302A1 (en) * 2008-09-17 2010-03-18 Traslational Cancer Drugs Pharma, S.L. Methods and compositions for the treatment of cancer
WO2010049173A1 (en) * 2008-10-31 2010-05-06 Cenix Bioscience Gmbh Use of inhibitors of host kinases for the treatment of infectious diseases
JP2013536203A (ja) * 2010-08-23 2013-09-19 スーチョウ・ニューファーマ・カンパニー・リミテッド 特定の化学成分、組成物および方法
EP3364956A4 (en) 2015-10-23 2019-05-01 ERX Pharmaceuticals, Inc. CELASTROL ANALOGUES
US10808005B2 (en) 2016-07-04 2020-10-20 Ixmedicine (Xiamen) Biological Technology Company Limited Ligand for orphan nuclear receptor Nur77 and uses thereof
WO2018019681A1 (en) 2016-07-25 2018-02-01 Nerviano Medical Sciences S.R.L. Purine and 3-deazapurine analogues as choline kinase inhibitors
EP3652177A1 (en) 2017-07-11 2020-05-20 Nerviano Medical Sciences S.r.l. Pyrazolo-quinazoline derivatives as choline kinase inhibitors
WO2020257658A1 (en) 2019-06-20 2020-12-24 University Of Iowa Research Foundation Nanoparticles comprising quinone w methides and compositions for use
CN113827599A (zh) * 2021-09-23 2021-12-24 天津国际生物医药联合研究院 去甲泽拉木醛在抗登革病毒感染中的潜在应用
CN116023426A (zh) * 2022-12-30 2023-04-28 上海海洋大学 去甲泽拉木醛衍生物及其在制备抗癌药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4328309A (en) * 1980-07-02 1982-05-04 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Method for producing tripdiolide, triptolide and celastrol
DE4117854A1 (de) * 1991-05-31 1992-12-03 Wiemann Wolfram Verwendung mindestens eines celastroloids als bestandteil fuer ein arzneimittel zur behandlung von erkrankungen des rheumatoiden formenkreises, insbesondere rheumatismus
US5650167A (en) * 1995-11-16 1997-07-22 Dawa Incorporated Method and composition for treating hepatitis B
ES2117950B1 (es) 1996-08-02 1999-09-16 Univ Granada Nuevos compuestos que bloquean la biosintesis de fosforilcolina y su uso como segundo mensajero en proliferacion celular.
CN1155610C (zh) * 2002-11-05 2004-06-30 浙江大学 具有抗氧化和抗肿瘤活性扁蒴藤素系列衍生物及合成方法
US20040220267A1 (en) * 2003-02-07 2004-11-04 Devlin J. P. Derivatives of pentacyclic nortriterpene quinone methides as compounds useful in the treatment of inflammatory, neurodegenerative, and neoplastic diseases

Also Published As

Publication number Publication date
JP2009522239A (ja) 2009-06-11
ES2277568A1 (es) 2007-07-01
CA2635318A1 (en) 2007-07-12
ES2277568B1 (es) 2008-04-01
EP1976533A2 (en) 2008-10-08
WO2007077203A2 (en) 2007-07-12
AU2006334359A1 (en) 2007-07-12
KR20080083044A (ko) 2008-09-12
WO2007077203A3 (en) 2007-08-30
AU2006334359A2 (en) 2008-08-07
CN101351211A (zh) 2009-01-21
MX2008008556A (es) 2008-09-26
RU2008131311A (ru) 2010-02-10

Similar Documents

Publication Publication Date Title
BRPI0620845A2 (pt) derivados de triterpenoquinona e triterpenofenol e sua aplicação para o tratamento de tumores e doenças parasitárias
JP7248750B2 (ja) オピオイド受容体リガンド並びにそれらの使用方法及び製造方法
CN106103452B (zh) 皮质抑素类似物及其合成和用途
CN108794564B (zh) 常春藤皂苷元a环并吡嗪衍生物及其制备方法和用途
PT2125776T (pt) Compostos espiro substituídos como inibidores da angiogénese
KR19980702414A (ko) 벤조피란 함유 화합물 및 이들의 사용방법
UA79229C2 (en) 3-nitrogen-6,7-dioxygen steroids and uses related thereto
JP2010540471A (ja) ガンボギン酸グリコシド誘導体及びアナログ、並びにその製法及び応用
CN110526916B (zh) 氘代Capmatinib化合物及其用途
WO2016045505A1 (zh) 一种喜树碱类磷脂化合物、其药物组合物及应用
US8299125B2 (en) Water-soluble triterpenephenol compounds having antitumor activity and the preparation thereof
CN105085383B (zh) 5‑甲基‑2(1h)吡啶酮衍生物及其制备方法和用途
Rhee et al. Synthesis, cytotoxicity, and DNA topoisomerase II inhibitory activity of benzofuroquinolinediones
Volodina et al. Thiophene-2-carboxamide derivatives of anthraquinone: A new potent antitumor chemotype
AU2011278983B2 (en) New compounds for treating cancer and other diseases
Gao et al. Three new alkaloids from Veratrum grandiflorum Loes with inhibition activities on Hedgehog pathway
WO2020062883A1 (zh) 基于知母菝契皂苷元结构的衍生物、药物组合物及其应用
Huang et al. Straightforward synthesis of steroidal selenocyanates through oxidative umpolung selenocyanation of steroids and their antitumor activity
Luan et al. Synthesis and structure-activity relationship of lipo-diterpenoid alkaloids with potential target of topoisomerase IIα for breast cancer treatment
CN116462677A (zh) 一种多稠环prmt5抑制剂及其制备方法和应用
NO328418B1 (no) Pentacykliske taksanforbindelser, anvendelser derav, og medikamenter omfattende slike forbindelser.
CN106188211B (zh) 白桦脂酸衍生物及其应用
PT2044080T (pt) Derivados da camptotecina com atividade antitumoral
CA2931291C (en) Taxanes compounds, preparation method therefor, and uses thereof
CZ282473B6 (cs) Bis(fenyl)ethanové deriváty, způsob jejich přípravy a farmaceutická kompozice tyto deriváty obsahující

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]